164
4
17
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15389L |
Glucagon (1-29), bovine, human, porcine hydrochloride
盐酸胰高血糖素,Porcine glucagon hydrochloride,Glucagon hydrochloride |
Glucocorticoid Receptor; Glucagon Receptor | Endocrinology/Hormones; GPCR/G Protein |
Glucagon (1-29), bovine, human, porcine hydrochloride 是一种由胰腺 α 细胞产生的多肽激素。它可激活 HNF4α 并促进 HNF4α 磷酸化,促进糖异生。 | |||
TP1863L |
Glucagon (19-29), human acetate
|
Glucagon Receptor | GPCR/G Protein |
Glucagon (19-29), human acetate 是一种从胰高血糖素加工而来的 COOH 末端片段,是一种有效的胰岛素分泌抑制剂。 | |||
TQ0239 |
PF-06291874
Glucagon receptor antagonists-4 |
Glucagon Receptor | GPCR/G Protein |
PF-06291874 (Glucagon receptor antagonists-4) 是口服有活性的胰高血糖素受体非肽类拮抗剂。它正用于研究 2 型糖尿病。 | |||
T36638 |
[Des-His1,Glu9]-Glucagon amide TFA
[Des-His1,Glu9]-Glucagon amide TFA |
||
[Des-His1,Glu9]-Glucagon amide TFA is a potent peptide antagonist targeting the glucagon receptor, featuring a pA2 value of 7.2. It holds potential utility in diabetes pathogenesis research[1]. | |||
T15389 |
Glucagon (1-29), bovine, human, porcine
胰高血糖素,Porcine glucagon,Glucagon |
Others | Others |
Glucagon is a peptide hormone, produced by pancreatic α-cells. Glucagon reduces the activity of HNF-4. Glucagon stimulates gluconeogenesis. Glucagon enhances HNF4α phosphorylation. | |||
T37223 |
Glucagon Receptor Antagonist I
|
||
Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM). It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver. Glucagon receptor antagonist I, at 50 mg/kg, reduces the increase in glucose levels observed after intraperitoneal administration of glucagon in humanized mice. Glucagon receptor antagonist inactive control does not prevent glucagon-mediated actions. | |||
TP2033 |
[Des-His1,Glu9]-Glucagon amide
des-His1-[Glu9]-Glucagon (1-29) amide |
||
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hy | |||
T78059 |
Glucagon (Human)
Hyperglycemic-glycogenolytic factor,Glukagon |
Others | Others |
Glucagon 对蛋白质和氨基酸的代谢产生显著的调节作用。它抑制了氨基酸与肝脏、肌肉以及胰腺蛋白的结合,增加氮的排出,并促进肝脏内尿素的合成。同时,Glucagon 增加了肝脏中转氨酶和尿素循环酶的浓度,提高了肝脏对氨基酸的摄取,并加强了氨基酸与肝糖原之间的结合,从而降低了血液中的氨基酸浓度。 | |||
T36580 |
Glucagon Receptor Antagonist Inactive Control
|
||
Glucagon Receptor Antagonist Inactive Control 是一种 Glucagon 受体拮抗剂,可用于生命科学领域的相关研究。其产品编号为 T36580,CAS号为 362482-00-6。 | |||
T11413 |
Glucagon receptor antagonists-1
|
Others | Others |
Glucagon receptor antagonist -1 is a highly effective glucagon receptor antagonist. | |||
TP1863 |
Glucagon (19-29), human
|
||
Glucagon is a 29-amino-acid peptide hormone liberated in the alpha cells of the islets of Langerhans. Glucagon-producing alpha cells represent one of the earliest populations of detectable islet cells in the developing endocrine pancreas. | |||
T11416 | Glucagon receptor antagonists-5 | Others | Others |
Glucagon receptor antagonists-5 is an orally bioavailable indazole-based glucagon receptor antagonist (Ki: 32 nM). It has potential for the treatment of type 2 diabetes mellitus (T2DM). | |||
T11415 |
Glucagon receptor antagonists-3
|
Others | Others |
Glucagon receptor antagonist -3 is a highly effective glucagon receptor antagonist. | |||
T11414 |
Glucagon receptor antagonists-2
|
Others | Others |
Glucagon receptor antagonist -2 is a highly effective glucagon receptor antagonist. | |||
TP1148L |
Glucagon-like peptide 1 (1-37), human acetate
|
Glucagon Receptor | GPCR/G Protein |
Glucagon-like peptide 1 (1-37), human acetate 是一种高效的 GLP-1 受体激动剂。 | |||
TP1487 |
Glucagon-Like Peptide (GLP) II, human
|
||
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a po | |||
T80030 |
Oxyntomodulin (bovine, porcine) (TFA)
Glucagon-37 (bovine, porcine) (TFA) |
||
Oxyntomodulin (bovine, porcine) TFA为含37个氨基酸的肽类激素,作为胰高血糖素样肽1 (GLP-1) 受体的激动剂。 | |||
TQ0124 |
BETP
|
Glucagon Receptor | GPCR/G Protein |
BETP 是胰高血糖素样肽 (GLP-1) 受体激动剂,能够抑制人和大鼠的GLP-1受体,其EC50值分别为 0.66 μM 和 0.755 μM。 | |||
TP1148 |
Glucagon-like peptide 1 (1-37), human
HuGLP-1 |
||
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not en | |||
T82306 |
Glucagon (22-29)
|
||
Glucagon (22-29) 作为Glucagon (19–29)的部分激动剂,能特异性抑制肝质膜 Ca2+泵,其作用机制与腺苷酸环化酶激活无关。 | |||
TP1147 |
Glucagon-like peptide 1 (1-37), human TFA
HuGLP-1 TFA |
||
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon. | |||
T11845 |
LGD-6972
|
Glucagon Receptor | GPCR/G Protein |
LGD-6972 是口服有活性的胰高血糖素受体选择性拮抗剂,能够用于研究 2 型糖尿病。 | |||
T80453 |
GLP-1 (1-36) amide (human, rat)
Glucagon-like Peptide 1 (1-36) amide (human, rat) |
||
GLP-1(1-36) amide (human, rat)(人类及大鼠的胰高血糖素样肽1(1-36)酰胺)是GLP-1(7-36)酰胺的一种分子变体。该化合物能激发[14C]氨基吡啶在大鼠胃壁细胞的酶分散体中积累。 | |||
T7364 |
NNC-0640
|
Glucagon Receptor | GPCR/G Protein |
NNC-0640 是人类胰高血糖素受体阴性变构调节剂(IC50:69.2 nM)。 | |||
T76326 |
[Des-His1,Glu9] Glucagon
|
||
[Des-His1,Glu9] Glucagon 是一种有效的胰高血糖素受体系统多肽拮抗剂。[Des-His1,Glu9] Glucagon 增强胰岛细胞在葡萄糖刺激下释放胰岛素。[Des-His1,Glu9] Glucagon 可用于糖尿病的研究。 | |||
TP1157 |
GLP-2(1-33)(human)
GLP-2 (human),Glucagon-like peptide 2 (human) |
||
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. | |||
T8748 |
Exendin-4 acetate
|
Glucagon Receptor | GPCR/G Protein |
Exendin-4 acetate 是一种长效的 glucagon-likepeptide-1 受体激动剂(IC50:3.22 nM),是一种由39个氨基酸组成的多肽。。 | |||
T82309 |
GLP-1 (1-36) amide (human, rat) (TFA)
Glucagon-like Peptide 1 (1-36) amide (human, rat) (TFA) |
||
GLP-1(1-36) amide (human, rat) TFA为胰高血糖素样肽1(GLP-1)-(7-36)酰胺的分子变体,能够促进[14C]氨基吡啶在大鼠壁细胞的酶分散体中的积累。 | |||
TP2252 |
GLP-1 (9-36) amide
|
Glucagon Receptor | GPCR/G Protein |
GLP-1(9-36)amide 是胰高血糖素样肽-1 (7-36) amide 的主要代谢产物,对人胰腺 GLP-1受体具有拮抗作用。 | |||
T83550 |
(Asp28)-Glucagon (1-29) (human, rat, porcine)
|
||
'(Asp28)-Glucagon (1-29) (human, rat, porcine)' 为胰高血糖素的一种改良型结构,在第28位氨基酸残基上天冬氨酸(Asp)替换原有残基,显著提高了该化合物在生理pH条件下的溶解性,且保持了与天然胰高血糖素相同的生物活性。 | |||
T76332 |
Biotinyl-Glucagon (1-29), human, bovine, porcine
|
||
Biotinyl-Glucagon (1-29), human, bovine, porcine 为带生物素标记的Glucagon衍生物,此肽类激素由胰腺α细胞分泌,功能是提升血液中的葡萄糖与脂肪酸浓度。 | |||
T19850 |
Semaglutide
索玛鲁肽,司美格鲁肽,索马鲁肽 |
Glucagon Receptor | GPCR/G Protein |
Semaglutide 是人胰高血糖素样肽-1受体激动剂,是一种人胰高血糖素样肽-1 的长效类似物。它有用于 2 型糖尿病研究的潜力。 | |||
T0178 |
Saxagliptin hydrate
沙格列汀单水化合物,Onglyza hydrate,BMS-477118 hydrate |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin hydrate (Onglyza hydrate) 是一种选择性,竞争性,可逆性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin hydrate 能够用于 2 型糖尿病的研究。 | |||
T3984 |
GLP-1(7-36), amide
MKC 253,胰高血糖素样肽-1,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide |
Glucagon Receptor | GPCR/G Protein |
GLP-1(7-36), amide (MKC 253) 是一种生理性肠降血糖素,能够刺激胰岛素分泌。 | |||
T6203 |
Saxagliptin
BMS-477118,沙克列汀,Onglyza,沙格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Saxagliptin (BMS-477118) 是一种选择性,可逆性,竞争性和口服活性的二肽基肽酶 4 (DPP-4) (Ki= 0.6-1.3 nM) 抑制剂。Saxagliptin 能够用于 2 型糖尿病的研究。 | |||
T76628 |
(Met(O)27)-Glucagon (1-29) (human, rat, porcine)
|
||
'(Met(O)27)-Glucagon (1-29) (human, rat, porcine) 为修饰版胰高血糖素。在大鼠肝细胞内,其促进葡萄糖合成的活性虽与天然胰高血糖素相似,但呈现出较低效率,暗示蛋氨酸对于胰高血糖素与其肝脏受体绑定具有关键性作用。' | |||
T3422 |
GRA Ex-25
GRA-Ex-25 |
Glucagon Receptor | GPCR/G Protein |
GRA Ex-25 (GRA-Ex-25) 是glucagon 受体抑制剂,其对大鼠和人的 glucagon 受体的IC50值分别为 56 和 55 nM。 | |||
T3967 |
Exendin-4
艾塞那肽,Exenatide,Exenatide Acetate |
Glucagon Receptor | GPCR/G Protein |
Exendin-4 (Exenatide) 是一种长效的 glucagon-likepeptide-1 受体激动剂(IC50: 3.22 nM),是一种由 39 个氨基酸组成的多肽。 | |||
T76330 |
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide
|
||
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide 是一种带有生物素标签的Glucagon-like peptide-1-(7-36),后者为一种具备提升胰岛素释放功能,从而表现出抗糖尿病活性的胃肠道肽。 | |||
TP1039 |
Secretin (33-59), rat
大鼠SECRETIN肽,Secretin (rat) |
Glucagon Receptor | GPCR/G Protein |
Secretin (33-59), rat (Secretin (rat)) 是由 27 个氨基酸组成的多肽。Secretin (33-59), rat 可作用于分泌素受体,能够增强胰腺的碳酸盐、酶和钾离子的分泌。 | |||
T26712 |
AZD-1656
AZD 1656 |
Glucokinase | Metabolism |
AZD-1656 是口服有效的葡萄糖激酶选择性激活剂,EC50为 60 nM。AZD1656在2 型糖尿病中有研究的价值。 | |||
T6876 |
Liraglutide
利拉鲁肽,Liraglutidum,利拉糖肽,Victoza,Liraglutida,NN2211 |
Glucagon Receptor | GPCR/G Protein |
Liraglutide (Liraglutida) 是胰高血糖素样肽-1 受体激动剂,用于 2 型糖尿病的研究。 | |||
TP1469 |
Lixisenatide acetate (320367-13-3 free base)
Lixisenatide acetate |
Glucagon Receptor | GPCR/G Protein |
Lixisenatide acetate 是一种胰高血糖素样肽 1 受体的激动剂,可用于研究 2 型糖尿病。 | |||
T76085 |
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human
|
||
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human 是一种被 C 端标记的生物素化 GLP-1(7-36) 酰胺。 | |||
TP2100 |
Avexitide
Exendin-3 (9-39) amide,Exendin (9-39),艾塞那肽 |
Glucagon Receptor | GPCR/G Protein |
Avexitide (Exendin-3 (9-39) amide) 是一种特异竞争性的glucagon-like peptide-1 (GLP-1)受体拮抗剂。 | |||
T2316 |
Omarigliptin
MK-3102,奥格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Omarigliptin (MK-3102) 是高效选择性 DPP4抑制剂,IC50=为1.6nM。 | |||
TP1376 |
GLP-1(7-37) acetate(106612-94-6 free base)
GLP-1(7-37) acetate |
Others; Glucagon Receptor | GPCR/G Protein; Others |
GLP-1(7-37) acetate 是肠道胰岛素激素,能够促进葡萄糖诱导的胰岛素分泌。 | |||
T60047 |
V-0219
|
Glucagon Receptor | GPCR/G Protein |
V-0219 是 GLP-1 的正变构调节剂,可用于肥胖相关糖尿病的研究。 | |||
T9579 |
GLP-1 receptor agonist 9
|
Glucagon Receptor | GPCR/G Protein |
1H-Benzimidazole-6-carboxylic acid 是GLP-1 receptor 激动剂。 | |||
T8947 |
dasiglucagon acetate
dasiglucagon acetate(1544300-84-6 free base) |
Others | Others |
dasiglucagon acetate 是一种用于糖尿病低血糖治疗的新型胰高血糖素类似物。 它已证明在水性制剂中的溶解度和稳定性。药代动力学研究表明,与传统的重组胰高血糖素相比,它的胰高血糖素具有更高的吸收率和更长的血浆消除半衰期。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3896 |
Shanzhiside methyl ester
三栀子甙甲酯,山芝皂苷甲酯 |
Glucagon Receptor | GPCR/G Protein |
Shanzhiside methyl ester 是一种小分子胰高血糖素样肽 1 受体激动剂,分离自轮状乳杆菌,能够诱导抗异常性痛觉耐受。 | |||
T37526 |
2-Oleoylglycerol
2-Oleoyl Glycerol,2-OG,2-Monoolein |
GPR | Endocrinology/Hormones; GPCR/G Protein |
2-Oleoylglycerol 是一种存在于棕榈仁、葵花籽和米糠中的脂质。2-Oleoylglycerol 可当作一种 GPR119 激动剂,具有神经保护作用,可诱导胰高血糖素样肽 1 (GLP-1) 分泌。2-Oleoylglycerol 可用于非酒精性脂肪性肝炎造模。 | |||
T37298 |
Spinacine
|
Endogenous Metabolite | Metabolism |
Spinacine 是人内源性代谢产物。 | |||
TN4997 |
Serpentine
|
IGF-1R | Tyrosine Kinase/Adaptors |
Serpentine 是一种玫瑰花根中的生物碱,可用作胰岛素增敏剂,以协助胰岛素降低血糖。Serpentine 可激活 AMPK 磷酸化,从而刺激C2C12细胞对葡萄糖的摄取。Serpentine 可增加了肌肉组织中GSK-3β mRNA的表达,从而增强葡萄糖摄取。Serpentine 显著增加胰高血糖素分泌和肝糖异生。在高脂肪饮食/链脲佐菌素(HFD/STZ)诱导的糖尿病小鼠中,Serpentine 显著延长了胰岛素的降血糖时间,显著降低了外源性胰岛素的使用,抑制了内源性胰岛素的分泌。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06864 |
GLP1R Protein, Human, Recombinant (His & Avi)
glucagon-like peptide 1 receptor |
Human | HEK293 Cells |
Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. GLP1R plays a critical role in mediating the biological actions of GLP1 in mammals and fish. The neuronal GLP1Rs mediate body weight and anorectic effects of liraglutide, but are not required for glucose-lowering effects. Glucagon-like peptide 1 receptor (GLP1R) signaling has been shown to have antipsychotic properties in animal models and to impact glucose-dependent insulin release, satiety, memory, and learning in man. Glucagon-like p... | |||
TMPJ-00742 |
GCG Protein, Human, Recombinant (His)
Glicentin,GRPP,GLP-2,Glucagon-Like Peptide 1,OXM, |
Human | HEK293 Cells |
Glucagon is a secreted protein and belongs to the glucagon family. Glucagon can be cleved into 8 chains, playing an important role in initiating and maintaining hyperglycemic conditions in diabetes. Glucagon can regulates blood glucose by decreasing glycolysis and increasing gluconeogenesis. In addition, Glucagon is involved in initiating and maintaining hyperglycemic conditions in diabetes. Glucagon release is stimulated by hypoglycemia and inhibited by hyperglycemia, insulin, and somatostatin.... | |||
TMPH-02628 |
Cathepsin C Protein, Mouse, Recombinant (His & Myc)
Dipeptidyl transferase,Dipeptidyl peptidase I,Cathepsin J,DP... |
Mouse | E. coli |
Thiol protease. Has dipeptidylpeptidase activity. Can act as both an exopeptidase and endopeptidase. Can degrade glucagon. Plays a role in the generation of cytotoxic lymphocyte effector function. | |||
TMPH-01386 |
GLP2R Protein, Human, Recombinant (His)
|
Human | HEK293 Cells |
This is a receptor for glucagon-like peptide 2. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. GLP2R Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-10xHis tag. The predicted molecular weight is 22.0 kDa and the accession number is O95838. | |||
TMPH-03583 |
Extracellular elastase Protein, S. epidermidis, Recombinant (His & Myc)
|
Staphylococcus epidermidis | E. coli |
Protease that has a low substrate specificity. Glucagon is preferentially cleaved between aromatic (Phe) and hydrophobic (Val) amino acids. Hydrolyzes casein and elastin. Extracellular elastase Protein, S. epidermidis, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 37.7 kDa and the accession number is P0C0Q4. | |||
TMPJ-00851 |
IDE Protein, Human, Recombinant (His)
Insulysin,Insulinase,Insulin-Degrading Enzyme,IDE,Abeta-Degr... |
Human | HEK293 Cells |
Insulin-Degrading Enzyme (IDE) is a secreted enzyme that belongs to the peptidase M16 family. IDE is a large zinc-binding protease and cleaves multiple short polypeptides that vary considerably in sequence. IDE plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin, and other peptides, and thereby plays a role in intercellular peptide signaling. IDE degrades amyloid formed by APP and IAPP. IDE may participate in the degradation and clearance of naturally secreted... | |||
TMPY-03597 |
VIP Protein, Human, Recombinant (His)
PHM27,vasoactive intestinal peptide |
Human | HEK293 Cells |
VIP, or vasoactive intestinal peptide, is a neuropeptide of 28 amino acid residues that belongs to a glucagon/secretin superfamily, and it exerts its actions through three G-protein-coupled receptors (PAC1, VPAC1, and VPAC2). VIP is synthesized by trophoblast cells; it regulates trophoblast cell function and interaction with the major immune cell populations present in the pregnant uterus. | |||
TMPH-01385 |
GLP1R Protein, Human, Recombinant (His)
|
Human | HEK293 Cells |
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1. GLP1R Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with N-6xHis tag. The predicted molecular weight is 18.3 kDa and the accession number is P43220. | |||
TMPH-03301 |
GLP1R Protein, Rat, Recombinant (E. coli, His)
|
Rat | E. coli |
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1. GLP1R Protein, Rat, Recombinant (E. coli, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 17.1 kDa and the accession number is P32301. | |||
TMPH-02676 |
GLP1R Protein, Mouse, Recombinant (His & SUMO)
|
Mouse | E. coli |
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1. GLP1R Protein, Mouse, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 30.4 kDa and the accession number is O35659. | |||
TMPH-01384 |
GLP1R Protein, Human, Recombinant (E. coli, His)
|
Human | E. coli |
G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1. GLP1R Protein, Human, Recombinant (E. coli, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 18.3 kDa and the accession number is P43220. | |||
TMPK-00036 |
GIP Protein, Human, Recombinant (His)
Incretin,GIP |
Human | HEK293 Cells |
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals. GIP Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cell... | |||
TMPK-00890 |
GIP Protein, Mouse, Recombinant (hFc)
Incretin,GIP |
Mouse | HEK293 Cells |
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals. GIP Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cell... | |||
TMPK-00891 |
GIP Protein, Mouse, Recombinant (His)
GIP,Incretin |
Mouse | HEK293 Cells |
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals. GIP Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cell... | |||
TMPH-02675 |
GCGR Protein, Mouse, Recombinant (GST)
|
Mouse | E. coli |
G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and gluconeogenesis. Plays an important role in mediating the responses to fasting. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. ... | |||
TMPY-02979 |
HMGN3 Protein, Human, Recombinant (His)
PNAS-24,TRIP7,PNAS-25,high mobility group nucleosomal bindin... |
Human | E. coli |
HMGN3 belongs to the HMGN family and is expressed in the kidney, lung, pancreas, testis, skeletal muscle, heart, thyroid gland, pituitary gland, prostate, and uterus. Members of the HMGN family bind to nucleosomes without any specificity for the underlying DNA sequence. They affect the global and local structure of chromatin, as well as the levels of histone modifications, and thus play a role in epigenetic regulation of gene expression. HMGN3 regulates the expression of the glucose transporter ... | |||
TMPY-02640 |
FAM3B Protein, Human, Recombinant (hFc)
PANDER,ORF9,PRED44,C21orf11,C21orf76,42056,family with seque... |
Human | HEK293 Cells |
Pancreatic derived factor, also known as FAM3B, is an islet-specific secreted cytokine specifically expressed at high levels in the islets of Langerhans of the endocrine pancreas. FAM3B protein is present in alpha- and beta- cells of pancreatic islets, insulin-secreting beta-TC3 cells, and glucagon-secreting alpha-TC cells. FAM3B causes apoptosis of beta-cells as assessed by electron microscopy, annexin Ⅴ fluorescent staining, and flow-cytometric terminal deoxynucleotidyl transferase-mediated dU... |